跳至主要内容
临床试验/NCT03927807
NCT03927807Unknown2 期

A Comparison of the Efficacy and Safety of Repetitive Hourly Dose of Oral Misoprostol and Two Hourly Dose Oral Regimens for Cervical Ripening and Labor Induction

Ain Shams University1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2019年3月18日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
150
试验地点
1
主要终点
Mode of delivery

研究概览

简要总结

This study compares safety and efficacy between repetitive hourly dose of oral misoprostol and two hourly dose oral regimens for cervical ripening and labor induction.

详细描述

Misoprostol is an effective agent for the induction of labor.existing guidelines recommend oral misoprostol solution every two hours.However,more research is required to optimize the use of oral misoprostol solution for labor induction.The current study is to compare efficacy and safety of repetitive hourly dose of oral misoprostol solution with two hourly dose of oral misoprostol solution for cervical ripening and labor induction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

性别
Female
接受健康志愿者

入选标准

  • Nulliparas
  • Term pregnancy(equal or more than 37 wks)
  • Bishop score <6
  • Cephalic presentation
  • reassuring fetal heart rate pattern
  • Not in labor ( no uterine contractions)
  • Clinically adequate pelvis
  • Singleton live pregnancy

排除标准

  • Allergic to misoprostol or prostaglandin analogues
  • Previous uterine scar( cesarean section,hysterotomy,myomectomy)
  • Multiple fetal gestations
  • Fetal demise
  • Preterm labor
  • Malpresentations
  • Non reactive cardiotocography at admission
  • Cephalo pelvic disproportion
  • Fetal macrosomia

研究组 & 干预措施

repetitive hourly dose of oral misoprostol

Experimental

The dose will be 10 microgram oral misoprostol that will be administered hourly up to 12 doses or till onset of regular uterine activity.

干预措施: Misoprostol (Drug)

two hourly dose of oral misoprostol

Experimental

The dose will be 20 microgram oral misoprostol solution that will be administered every 2 hours up to 6 doses or till onset of regular uterine activity.

干预措施: Misoprostol (Drug)

结局指标

主要结局

Mode of delivery

时间窗: 24 hours from the first dose of induction till delivery

Successful vaginal delivery within 24 hours from starting induction of labor or cesarean section delivery after failed trial of induction.

次要结局

  • Adverse neonatal outcomes(24 hours post partum)
  • Adverse maternal outcomes(in 24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Esam salah mohamed hagag

Director,clinical research

Ain Shams University

研究点 (1)

Loading locations...

相似试验